[Enhanced chemotherapeutic drug delivery to tumor tissue by high intensity focused ultrasound].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Jung JT;Jung JT; Lee DH; Hwang JH
  • Source:
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi [Korean J Gastroenterol] 2009 Apr; Vol. 53 (4), pp. 216-20.
  • Publication Type:
    English Abstract; Journal Article; Review
  • Language:
    Korean
  • Additional Information
    • Source:
      Publisher: Korean Society of Gastroenterology Country of Publication: Korea (South) NLM ID: 101189416 Publication Model: Print Cited Medium: Print ISSN: 1598-9992 (Print) Linking ISSN: 15989992 NLM ISO Abbreviation: Korean J Gastroenterol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Seoul, Korea : Korean Society of Gastroenterology, [2003]-
    • Subject Terms:
    • Abstract:
      Cancer is the first leading cause of death in Korea. Systemic chemotherapy is currently the standard treatment for a wide variety of cancers; however, in the majority of cases, cure is not achieved, and the attendant side effects of the treatment are considerable. The effectiveness of chemotherapy in cancers depends on the adequate delivery of the chemotherapeutic agent to cancer cells. The achievement of uniform drug delivery of chemotherapeutic agents throughout tumors is limited by the anomalous vascularization and blood vessel permeability. Ultrasound has an ever-increasing role in the delivery of therapeutic agents including chemotherapeutic agents, proteins, and genetic materials. Ultrasound technology allows for the use of focused ultrasound energy for therapeutic purposes by delivering high-intensity focused ultrasound for applications such as tissue ablation, and enhanced drug delivery. We reviewed recent work in the emerging field of ultrasound-based therapeutics, with particular emphasis on the delivery of drugs to tumor tissue.
    • Number of References:
      29
    • Accession Number:
      0 (Antineoplastic Agents)
    • Publication Date:
      Date Created: 20090422 Date Completed: 20090702 Latest Revision: 20170309
    • Publication Date:
      20240829
    • Accession Number:
      19381053